This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Otago Innovation Limited. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Jacqueline Amanda Lee: Innovator in Cardiac Disorder Diagnostics
Introduction
Jacqueline Amanda Lee is a prominent inventor based in Christchurch, New Zealand. She has made significant contributions to the field of medical diagnostics, particularly in the area of cardiac disorders. Her innovative work has the potential to enhance the prognosis and diagnosis of various cardiac conditions.
Latest Patents
Jacqueline holds 1 patent for her invention titled "Biomarker for Cardiac Disorders." This invention relates to assays, methods, and kits designed for the prognosis and diagnosis of cardiac disorders. It introduces binding agents to a novel class of circulating cardiac troponin T upstream open reading frame (TnTuORF) peptide biomarkers. These biomarkers are crucial for predicting or diagnosing cardiac disorders beyond myocardial infarction or unstable angina. Furthermore, the binding agents can improve the sensitivity and reduce false positive rates of cardiac troponins in diagnosing myocardial infarction.
Career Highlights
Jacqueline is associated with Otago Innovation Limited, where she applies her expertise in developing innovative solutions for healthcare challenges. Her work is characterized by a commitment to advancing medical technology and improving patient outcomes.
Collaborations
Jacqueline collaborates with Christopher Joseph Pemberton, leveraging their combined expertise to drive innovation in cardiac diagnostics.
Conclusion
Jacqueline Amanda Lee's contributions to the field of cardiac disorder diagnostics exemplify her dedication to innovation and improving healthcare. Her work not only enhances diagnostic accuracy but also holds promise for better patient care in the future.